BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 18407491)

  • 1. Exploring the Potential of Sulfur Moieties in Compounds Inhibiting Steroidogenesis.
    Wróbel TM; Sharma K; Mannella I; Oliaro-Bosso S; Nieckarz P; Du Toit T; Voegel CD; Rojas Velazquez MN; Yakubu J; Matveeva A; Therkelsen S; Jørgensen FS; Pandey AV; Pippione AC; Lolli ML; Boschi D; Björkling F
    Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-steroidal CYP17A1 Inhibitors: Discovery and Assessment.
    Wróbel TM; Jørgensen FS; Pandey AV; Grudzińska A; Sharma K; Yakubu J; Björkling F
    J Med Chem; 2023 May; 66(10):6542-6566. PubMed ID: 37191389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a range of phenyl alkyl imidazole-based compounds as potent inhibitors of the enzyme complex 17alpha-hydroxylase/17,20-lyase (P450(17alpha)).
    Owen CP; Shahid I; Olusanjo MS; Patel CH; Dhanani S; Ahmed S
    J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):117-27. PubMed ID: 18620055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biochemical evaluation of a range of potent benzyl imidazole-based compounds as potential inhibitors of the enzyme complex 17alpha-hydroxylase/17,20-lyase (P450(17alpha)).
    Owen CP; Dhanani S; Patel CH; Shahid I; Ahmed S
    Bioorg Med Chem Lett; 2006 Aug; 16(15):4011-5. PubMed ID: 16750362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a range of 4-substituted phenyl alkyl imidazole-based inhibitors of the enzyme complex 17alpha-hydroxylase/17,20-lyase (P450(17alpha)).
    Patel CH; Dhanani S; Owen CP; Ahmed S
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4752-6. PubMed ID: 16870430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biochemical evaluation of a range of (4-substituted phenyl)sulfonate derivatives of 4-hydroxybenzyl imidazole-based compounds as potent inhibitors of 17alpha-hydroxylase/17,20-lyase (P45017alpha) derived from rat testicular microsomes.
    Owen CP; Shahid I; Lee WY; Ahmed S
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5345-8. PubMed ID: 20675132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biochemical evaluation of a range of sulfonated derivatives of 4-hydroxybenzyl imidazole as highly potent inhibitors of rat testicular 17alpha-hydroxylase/17,20-lyase (P-450(17alpha)).
    Ahmed S; Shahid I; Dhanani S; Owen CP
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4698-701. PubMed ID: 19608417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biochemical evaluation of a range of potent 4-substituted phenyl alkyl imidazole-based inhibitors of the enzyme complex 17alpha-Hydroxylase/17,20-Lyase (P45017alpha).
    Shahid I; Patel CH; Dhanani S; Owen CP; Ahmed S
    J Steroid Biochem Mol Biol; 2008 May; 110(1-2):18-29. PubMed ID: 18407491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 17alpha-hydroxylase/17,20-lyase (p450(17alpha)) inhibitors in the treatment of prostate cancer: a review.
    Owen CP
    Anticancer Agents Med Chem; 2009 Jul; 9(6):613-26. PubMed ID: 19601745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of p450 17 as a new strategy for the treatment of prostate cancer.
    Leroux F
    Curr Med Chem; 2005; 12(14):1623-9. PubMed ID: 16022662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in the study of steroidal inhibitors of cytochrome P45017alpha].
    Du JJ; Chen HL; Li YC
    Yao Xue Xue Bao; 2013 Jan; 48(1):25-31. PubMed ID: 23600137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP17 inhibitors for prostate cancer treatment--an update.
    Moreira VM; Salvador JA; Vasaitis TS; Njar VC
    Curr Med Chem; 2008; 15(9):868-99. PubMed ID: 18473796
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.